US Broker Ratings

argenx SE (ARGX) Stock Analysis: High Growth and Strong Buy Ratings Amidst a 17.83% Upside Potential

argenx SE (ARGX), a prominent player in the biotechnology industry, is gaining significant attention from investors due to its remarkable growth metrics and a robust pipeline of therapies targeting autoimmune..

The Cooper Companies, Inc. (COO) Stock Analysis: Potential 16.19% Upside in Healthcare Sector

The Cooper Companies, Inc. (NYSE: COO), a titan in the healthcare sector specializing in medical instruments and supplies, is capturing attention with its compelling market presence and potential upside. With..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Understanding Its 8.75% Potential Upside

Investors looking for opportunities in the healthcare sector should turn their attention to Thermo Fisher Scientific Inc. (NYSE: TMO), a behemoth in the diagnostics and research industry. With a market..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Is a 43.53% Upside Within Reach?

Intuitive Surgical, Inc. (ISRG), a titan in the healthcare sector, has been making waves with its innovative contributions to minimally invasive surgery. Headquartered in Sunnyvale, California, the company is renowned..

AbbVie Inc. (ABBV) Stock Analysis: A Healthcare Giant with a Promising 3.25% Upside

AbbVie Inc. (NYSE: ABBV), a research-based biopharmaceutical powerhouse, commands the attention of investors with its robust portfolio of therapies and medications. With a market capitalization of $458.24 billion, AbbVie stands..

Haleon plc (HLN) Stock Analysis: A 19.12% Upside Potential Awaits Investors in the Healthcare Sector

Haleon plc (HLN), a prominent player in the healthcare sector, offers a compelling proposition for individual investors seeking exposure to the burgeoning field of consumer healthcare. With its headquarters in..

BeOne Medicines Ltd. (ONC) Stock Analysis: A 27.54% Upside Potential with a Strong Buy Consensus

BeOne Medicines Ltd. (ONC) is capturing the attention of investors with its promising growth prospects and robust pipeline in the biotechnology sector. Headquartered in Basel, Switzerland, this oncology-focused company is..

Natera, Inc. (NTRA) Stock Analysis: Unpacking the 38.8% Revenue Growth and Investor Ratings

Natera, Inc. (NASDAQ: NTRA), headquartered in Austin, Texas, is a prominent player in the healthcare sector, specifically within the diagnostics and research industry. The company is renowned for its cutting-edge..

Sanofi (SNY) Stock Analysis: Evaluating a 27% Upside Potential in Healthcare Giant

Sanofi (NASDAQ: SNY), a stalwart in the healthcare sector, continues to capture investor attention with its promising 27% potential upside. As a global leader in drug manufacturing, Sanofi is headquartered..

Veeva Systems Inc. (VEEV) Investor Outlook: A Promising 31% Potential Upside in the Healthcare Sector

Veeva Systems Inc. (NYSE: VEEV) stands out in the healthcare sector, particularly within the health information services industry, where it has carved a niche as a pivotal provider of cloud-based..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Exploring a 30.96% Potential Upside

GE HealthCare Technologies Inc. (NYSE: GEHC) presents an intriguing opportunity for investors with its strong position in the healthcare sector, particularly in the medical devices industry. Headquartered in Chicago, Illinois,..

CVS Health Corporation (CVS) Stock Analysis: Navigating Growth with a Forward P/E of 12.80

CVS Health Corporation (NYSE: CVS) stands as a formidable player in the healthcare sector, boasting a market capitalization of $137.47 billion. As a leader in healthcare plans within the United..

Cardinal Health (CAH) Stock Analysis: Navigating a 10.69% Potential Upside in the Healthcare Sector

Cardinal Health, Inc. (NYSE: CAH), a heavyweight in the healthcare sector, is drawing attention from investors with its promising potential upside of 10.69%. As a key player in the medical..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Exploring a 16.25% Potential Upside

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), a titan in the biotechnology sector, continues to capture investor attention with its promising pipeline and robust market presence. As of the latest trading session,..

GSK plc (GSK) Stock Analysis: Evaluating a 13.10% Potential Upside in the Healthcare Giant

GSK plc (NYSE: GSK), a stalwart in the healthcare sector with a market capitalization of $102.84 billion, commands significant attention from investors worldwide. Known for its robust portfolio of vaccines,..

The Cigna Group (CI) Investor Outlook: Strong Buy Ratings and a 17.73% Potential Upside

Investors keeping an eye on the healthcare sector should take note of The Cigna Group (CI), a giant in the healthcare plans industry with a market cap of $76.6 billion...

Elevance Health, Inc. (ELV) Stock Analysis: Exploring an 18.91% Potential Upside

Elevance Health, Inc. (NYSE: ELV), previously known as Anthem, Inc., stands as a formidable player in the healthcare sector, particularly within the healthcare plans industry. With a market capitalization of..

Pfizer, Inc. (PFE)

⚠️ No article content returned.

..

Johnson & Johnson (JNJ) Stock Analysis: Evaluating Growth Potential and Analyst Ratings

Johnson & Johnson (NYSE: JNJ), a titan in the healthcare sector, continues to captivate investors with its robust market presence and substantial growth prospects. With a market capitalization of $634.77..

Stryker Corporation (SYK) Stock Analysis: Healthcare Giant with a 17% Potential Upside

For investors seeking a stable yet promising player in the healthcare sector, Stryker Corporation (NYSE: SYK) presents a compelling opportunity. As a leading entity in the medical devices industry, Stryker’s..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds